Issue 1/2007

Bone marrow-derived cells: roles in solid tumor (1 — 6)

WU XIONG-ZHI, CHEN DAN, XIE GUANG-RU

Radiotherapy combined with hormonal therapy (RT-HT) in prostate cancer patients with low, intermediate, and high risk of biochemical recurrence: perspective and therapeutic gain analysis (7 — 15)

P. MILECKI, Z. KWIAS, DJJ. MARTENKA

New [1,2,4]triazolo[4,3-c]quinazoline enhances cisplatin- and temozolomide-induced growth inhibition and apoptosis in HL-60 cells (16 — 20)

L. CIPAK, S. LETASIOVA, A. REPICKY, S. JANTOVA

The AFT024 stromal cell line improves MDR1 gene transfer to CD34+ cells derived from human umbilical cord blood (21 — 28)

HUALING ZHANG, ZEQING WEN, SHOUMIN LAN, CHANGZHONG LI, JIANFENG LI, XIAOJING ZHANG

Mitochondrial transmembrane potential in spontaneous and camptothecininduced apoptosis of melanotic and amelanotic melanoma cells. (29 — 36)

M. CICHOREK, K. KOZLOWSKA, E. BRYL

Expression of heat shock protein 70 (HSP70) in patients with colorectal adenocarcinoma – immunohistochemistry and Western blot analysis (37 — 45)

Z. T. MILICEVIC, M. Z. PETKOVIC, N. C. DRNDAREVIC, M. D. PAVLOVIC, V. N. TODOROVIC

Prognostic significance of clusterin immunoreactivity in breast cancer (46 — 50)

S. KRUGER, V. OLA, D. FISCHER, A. C. FELLER, M. FRIEDRICH

Independent origin of 185delAG BRCA1 mutation in an Indian family (51 — 56)

K. KADALMANI, S. DEEPA, S. BAGAVATHI, S. ANISHETTY, K. THANGARAJ, P. GAJALAKSHMI

Fine-needle aspiration biopsy-RT-PCR expression analysis of prothymosin α and parathymosin in thyroid: novel proliferation markers? (57 — 61)

K. P. LETSAS, G. VARTHOLOMATOS, C. TSEPI, A. TSATSOULIS, M. FRANGOU-LAZARIDIS

Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position (62 — 67)

P. SLAMPA, Z. PAVELKA, L. DUSEK, L. HYNKOVA, J. STERBA, B. ONDROVA, D. PRINC, T. NOVOTNY , S. KOSTAKOVA

In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine (68 — 74)

P. RAUKO, L. NOVOTNY, M. MEGO, P. SAIKO, H. SCHOTT, T. SZEKERES

Difficulties in the diagnosis of intracystic tumors of the female breast (75 — 82)

Z. S. EGYED, Z. PENTEK, K. ORMANDY, B. JARAY, J. KULKA, ZS. LASZLO

Interactions between smoking and other exposures associated with lung cancer risk in women: diet and physical activity (83 — 88)

A. KUBIK, P. ZATLOUKAL, L. TOMASEK, N. PAUK, L. HAVEL, J. DOLEZAL, I. PLESKO

Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT) (89 — 94)

M. DOUBEK, J. MUZIK, T. SZOTKOWSKI, V. KOZA, P. CETKOVSKY, T. KOZAK, P. ZAK, J. VOGLOVA, S. STRUNCOVA, L. DUSEK, K. INDRAK

The impact of positron emission tomography in the radiotherapy treatment planning (95 — 100)

H. DOLEZELOVA, P. SLAMPA

STK11/LKB1 germline mutations in the first Peutz-Jeghers syndrome patients identified in Slovakia (101 — 107)

Z. BARTOSOVA, K. ZAVODNA, T. KRIVULCIK, J. USAK, I. MLKVA, T. KRUZLIAK, J. HROMEC, V. USAKOVA, I. KOPECKA, P. VERES, Z. BARTOSOVA, M. BUJALKOVA

DNA-protective effects of two components of essential plant oils carvacrol and thymol on mammalian cells cultured in vitro (108 — 112)

D. SLAMENOVA, E. HORVATHOVA, M. SRAMKOVA, L. MARSALKOVA

Hsp70 induces Th1 polarization through tumor-associated macrophages in a T-cell lymphoma (113 — 122)

S. KUMAR, P. DEEPAK, A. ACHARYA

DAPK1 promoter hypermethylaiton in brain metastases and peripheral blood (123 — 126)

V. MARTINEZ-GLEZ, C. FRANCO-HERNANDEZ, P. GONZALEZ-GOMEZ, A. ISLA, J. M. DE CAMPOS, J. VAQUERO, M. GUTIERREZ, C. CASARTELLI, J. A. REY

Hsp90 inhibitor Geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin (127 — 130)

P. SOLAR, V. HORVATH, J. KLEBAN, J. KOVAL, Z. SOLAROVA, A. KOZUBIK, P. FEDOROCKO

Prognostic significances of oxidative DNA damage evaluated by 8-hydroxy-deoxyguanosine and antioxidant enzymes in patients undergoing resection of gastric and colon carcinoma (131 — 136)

Y. DINCER, S. HIMMETOGLU, T. AKCAY, E. Y. ERSOY, K. N. GUNES, O. TORTUM

The spectrum and incidence of BRCA1 pathogenic mutations in Slovak breast/ovarian cancer families (137 — 142)

M. KONECNY, M. VIZVARYOVA, E. WEISMANOVA, D. ILENCIKOVA, I. MLKVA, P. WEISMANN, G. MACHACKOVA, J. KAUSITZ

Simple variables predict survival after autologous transplantation: a single centre experience in 181 multiple myeloma patients (143 — 148)

M. KREJCI, R. HAJEK, T. BUCHLER, A. KRIVANOVA, A. SVOBODNIK, L. POUR, Z. ADAM, J. MAYER, J. VORLICEK

A Molecularly Genetic Determination of Prognostic Factors of the Prostate Cancer and Their Relationships to Expression of Protein p27kip1 (149 — 154)

J. DVORACKOVA, M. UVIROVA

Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population (155 — 161)

M. FRANEKOVA, P. ZUBOR, A. STANCLOVA, C. A. DUSSAN, T. BOHUSOVA, S. GALO, D. DOBROTA, K. KAJO, M. PEC, P. RACAY

Arterial blood pressure and baroreflex sensitivity 1 – 18 years after completing anthracycline therapy (162 — 167)

Z. NOVAKOVA, P. BALCARKOVA, N. HONZIKOVA, B. FISER, E. ZAVODNA, H. HRSTKOVA, K. KRONTORADOVA, J. STASTNA

Mucoepidermoid carcinoma of the breast (168 — 172)

H. HORNYCHOVA, A. RYSKA, J. BETLACH, R. BOHAC, T. CIZEK, M. TOMSOVA, R. OBERMANNOVA

Tumor induced by Moloney sarcoma virus causes periosteal osteogenesis engaging osteopontin, fibronectin, stromelysin-1 and tenascin. (173 — 179)

P. WLODARSKI, C. SEVIGNANI, M. J. FERNANDES, B. CALABRETTA, K. H. WLODARSKI

Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy (181 — 188)

B. MLADOSIEVICOVA, A. CARTER, V. KRISTOVA

Further characterization of the role of Pso2 in the repair of DNA interstrand cross-link-associated double-strand breaks in Saccharomyces cerevisiae (189 — 194)

A. DUDAS, D. VLASAKOVA, Z. DUDASOVA, D. GABCOVA, J. BROZMANOVA, M. CHOVANEC

Radiosensitivity of cervical cancer cell lines: the impact of polymorphisms in DNA repair genes (195 — 201)

S. GURSKA, T. FARKASOVA, A. GABELOVA

Flavonoids potentiate the efficacy of cytarabine through modulation of drug-induced apoptosis (202 — 206)

S. NADOVA, E. MIADOKOVA, L. CIPAK

Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: a tissue microarray and clinicopathological analysis (207 — 211)

S. HU, M. ZHANG, Z. LV, J. BI, Y. DONG, J. WEN

Incidence of the main genetic markers in glioblastoma multiforme is independent of tumor topology (212 — 218)

E. NECESALOVA, V. VRANOVA, P. KUGLIK, P. CEJPEK, M. JAROSOVA, M. PESAKOVA, J. RELICHOVA, R. VESELSKA

Carbonyl and oxidative stress in patients with breast cancer – is there a relation to the stage of the disease? (219 — 224)

P. TESAROVA, M. KALOUSOVA, B. TRNKOVA, J. SOUKUPOVA, S. ARGALASOVA, O. MESTEK, L. PETRUZELKA, T. ZIMA

Isotype class switching after transplantation in multiple myeloma (225 — 228)

V. MAISNAR, M. TICHY, L. SMOLEJ, P. ZAK, J. RADOCHA, V. PALICKA, J. MALY, V. BLAHA

Influence of heating on the activity of xanthine oxidase in tumor cells subjected to the phototoxic action of hematoporphyrin derivative (229 — 234)

L. CHEKULAYEVA, I. SHEVCHUK, V. CHEKULAYEV, E. OGINSKAYA

Association of cyclin D1 G870A polymorphism with susceptibility to gastric cancers in Korean male patients (235 — 239)

J. H. SONG, C. J. KIM, Y. G. CHO, Y. K. PARK, S. W. NAM, N. J. YOO, J. Y. LEE, W. S. PARK

Paclitaxel, Bleomycin, Etoposide, and Cisplatin (T-BEP) as initial treatment in patients with poor-prognosis germ cell tumors (GCT): A phase II study (240 — 245)

J. MARDIAK, T. SALEK, Z. SYCOVA-MILA, J. OBERTOVA, M. RECKOVA, M. MEGO, Z. HLAVATA, K. BROZMANOVA, Z. RISNYOVZSKA, D. SVETLOVSKA, I. KOZA

Increasing the repetition frequency of electric pulse delivery reduces unpleasant sensations that occur in electrochemotherapy (246 — 250)

A. ZUPANIC, S. RIBARIC, D. MIKLAVCIC

Effect of prolonged psychoemotional stress and melatonin on experimental mammary carcinogenesis in female rats (251 — 255)

M. KASSAYOVA, L. FRIEDMANOVA, P. ORENDAS, P. KUBATKA, B. BOJKOVA, N. BOBROV, E. AHLERSOVA, I. AHLERS

Sentinel node biopsy in breast cancer: short time results show appropriate regional control (256 — 261)

V. FAIT, V. CHRENKO

PML protein expression in hereditary and sporadic breast cancer (263 — 268)

P. PLEVOVA, J. BOUCHAL, M. FIURASKOVA, L. FORETOVA, M. NAVRATILOVA, J. ZAPLETALOVA, R. CURIK, O. KUBALA, J. PROKOP, Z. KOLAR

PML and TRF2 protein expression in hereditary and sporadic colon cancer (269 — 277)

P. PLEVOVA, J. BOUCHAL, M. FIURASKOVA, M. PAPEZOVA, A. KREPELOVA, R. CURIK, L. FORETOVA, M. NAVRATILOVA, J. ZAPLETALOVA, T. POSOLDA, Z. KOLAR

Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma (278 — 284)

M. RAICA, A. M. CIMPEAN, A. ANGHEL

Increased monocyte chemoattractant protein 1 (MCP-1/CCL-2) serum level in acute myeloid leukemia (285 — 289)

G. MAZUR, T. WROBEL, A. BUTRYM, K. KAPELKO-SLOWIK, R. POREBA, K. KULICZKOWSKI

Ratio of concentrations of estrogen receptors to progesterone receptors (ER/PR) in the cytosol of breast cancers (stratification by forming of groups differing in PR) (290 — 296)

J. HOCHMANN

Dendritic cell counts and their subsets during treatment of multiple myeloma (297 — 303)

L. KOVAROVA, T. BUCHLER, L. POUR, L. ZAHRADOVA, D. OCADLIKOVA, A. SVOBODNIK, M. PENKA, J. VORLICEK, R. HAJEK

A study on notch signaling in human breast cancer (304 — 310)

S. ZANG, CH. JI, XUN QU, X. DONG, D. MA, J. YE, R. MA, J. DAI, D. GUO

Growth inhibitory effect of the antibody to hematopoietic stem cell antigen CD34 in leukemic cell lines (311 — 320)

K. ELKNEROVA, Z. LACINOVA, J. SOUCEK, I. MARINOV, P. STOCKBAUER

Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases (321 — 325)

R. SALZMAN, K. KANKOVA, L. PACAL, J. TOMANDL, Z. HORAKOVA, R. KOSTRICA

Combination of Intratumoral injections of vaccinia virus MVA expressing GM-CSF and immunization with DNA vaccine prolongs the survival of mice bearing HPV16 induced tumors with downregulated expression of MHC class I molecules (326 — 333)

S. NEMECKOVA, M. SMAHEL, P. HAINZ, J. MACKOVA, K. ZURKOVA, P. GABRIEL, M. INDROVA, L. KUTINOVA

Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression? (334 — 341)

A. HLOBILKOVA, J. EHRMANN, E. SEDLAKOVA, V. KREJCI, P. KNIZETOVA, M. FIURASKOVA, M. KALA, O. KALITA, Z. KOLAR

Whole-body F-18 FDG PET for hepatocellular carcinoma patients after interventional treatment (342 — 347)

M. F. CHENG, Y. W. WU, K. Y. TZEN, Y. H. HUANG, R. F. YEN

Locally advanced breast carcinoma treated with neoadjuvant chemotherapy: are the changes in serum levels of YKL-40, MMP-2 and MMP-9 correlated with tumor response? (348 — 352)

U. COSKUN, D. YAMAC, O. GULBAHAR, B. SANCAK, N. KARAMAN, S. OZKAN

Prognostic factors in stage-i (T1N0) breast carcinoma patients: who needs adjuvant systemic treatment? (353 — 358)

E. YILDIRIM, U. BERBEROGLU

A karyometric study on ageing and butyrate or imatinib treated human leukemic myeloblasts represented by K562 cells originated from chronic myeloid leukaemia (359 — 364)

K. SMETANA, H. PILCOVA, M. PLUSKALOVA, Z. HRKAL

Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer (365 — 373)

E. PAPADOPOULOU, K. SIMOPOULOS, G. TRIPSIANIS, I. TENTES, K. ANAGNOSTOPOULOS, E. SIVRIDIS, G. GALAZIOS, A. KORTSARIS

The antioxidative role of selenium in pathogenesis of cancer of the female reproductive system (374 — 378)

K. PIEKUTOWSKI, R. MAKAREWICZ, B. A. ZACHARA

Tissue detection of natural killer cells in laryngeal carcinoma (379 — 382)

A. C. LAZARIS, J. V. SEGAS, T. P. NIKOLOPOULOS, E. S. PATSOURIS

Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia (383 — 390)

Z. TRNKOVA, R. BEDRLIKOVA, J. MARKOVA, K. MICHALOVA, P. STOCKBAUER, J. SCHWARZ

The role of clinical criteria, genetic and epigenetic alterations in Lynch-syndrome diagnosis (391 — 401)

A. ALEMAYEHU, K. TOMKOVA, K. ZAVODNA, K. VENTUSOVA, T. KRIVULCIK, M. BUJALKOVA, Z. BARTOSOVA, I. FRIDRICHOVA

Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease (402 — 406)

B. R. STANOJEVIC, P. LOHSE, G. G. NESKOVIC, S. M. DAMJANOVIC, T. B. NOVKOVIC, S. P. JOVANOVIC-CUPIC, B. B. DIMITRIJEVIC

Clinical, Pathological and Molecular Characteristics of Newly Diagnosed Breast Cancers (407 — 412)

J. PRAUSOVA, T. ECKSCHLAGER, M. MRHALOVA, A. SLOBODNIK, K. KUBACKOVA, S. VINAKURAU, R. KODET

Long-term outcome with interstitial brachytherapy boost in the treatment of women with early-stage breast cancer (413 — 423)

R. NEUMANOVA, J. PETERA, T. FRGALA, L. DUSEK, J. JARKOVSKY, R. KURICKA

Establishing the method of chimerism monitoring after allogeneic stem cell transplantation using multiplex polymerase chain reaction amplification of short tandem repeat markers and Amelogenin (424 — 430)

S. SUFLIARSKA, G. MINARIK, J. HORAKOVA, I. BODOVA, E. BOJTAROVA, B. CZAKO, M. MISTRIK, L. DRGONA, M. DEMITROVICOVA, J. LAKOTA, M. KRIVOSIKOVA, L. KOVACS

How can we help patients with refractory chronic graft versus host disease- single centre experience (431 — 436)

P. RZEPECKI, J. BARZAL, T. SAROSIEK, S. OBORSKA, C. SZCZYLIK

Nonseminomatous germ cell testicular tumors – clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only (437 — 442)

D. ONDRUS, M. ONDRUSOVA, M. HORNAK, J. MATOSKA

Reduced-intensity conditioning for allogeneic stem cell transplantation in patients with chronic myeloid leukemia is associated with better overall survival but inferior disease-free survival when compared with myeloablative conditioning – a retrospect (443 — 446)

E. FABER, V. KOZA, A. VITEK, J. MAYER, P. SEDLACEK, P. ZAK, J. ZAPLETALOVA, K. BENESOVA, H. KREJCOVA, K. STEINEROVA, I. MARESOVA, P. CETKOVSKY

Preoperative Radiotherapy and Concomitant Capecitabine Treatment Induce Thymidylate Synthase and Thymidine Phosphorylase mRNAs in Rectal Carcinoma (447 — 453)

I. KOCAKOVA, M. SVOBODA, K. KUBOSOVA, V. CHRENKO, E. ROUBALOVA, E. KREJCI, R. SEFR, P. SLAMPA, T. FRGALA, J. ZALOUDIK

Modulation of HLA-G expression (455 — 462)

K. POLAKOVA, E. BANDZUCHOVA, J. TIRPAKOVA, D. KUBA, G. RUSS

Comparison of inhibition of murine leukaemia cell growth by 9-isothiocyanatoacridine and its cytosine adduct: involvement of thiols (463 — 470)

M. BAJDICHOVA, H. PAULIKOVA, J. JAKUBIKOVA, D. SABOLOVA

Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia (471 — 477)

T. ZELEZNIKOVA, L. STEVULOVA, A. KOVARIKOVA, O. BABUSIKOVA

Comparative study of DNA-damaging and DNA-protective effects of selected components of essential plant oils in human leukemic cells K562 (478 — 483)

E. HORVATHOVA, V. TURCANIOVA, D. SLAMENOVA

Association of interleukin-8 (IL-8 or CXCL8) -251T/A and CXCR2 +1208C/T gene polymorphisms with breast cancer (484 — 489)

E. KAMALI-SARVESTANI, M.R. ALIPARASTI, S. ATEFI

Clonality analysis of intraductal proliferative lesions using the human androgen receptor assay (490 — 494)

H. LI, Q. CHEN, R. ZHU, D.H. GU, H.G. ZHU

Sensitization of colorectal cancer cells to irradiation by IL-4 and IL-10 is associated with inhibition of NF-κB (495 — 502)

R. VOBORIL, J. WEBEROVA-VOBORILOVA

JNK2 and p38 MAPK over-expressions do not represent key events in chronic myeloid leukemia transformation (503 — 510)

M. MERKEROVA, H. BRUCHOVA, R. BRDICKA

Molecular cytogenetic characterization and diagnostics of bladder cancer (511 — 516)

L. HOUSKOVA, Z. ZEMANOVA, M. BABJUK, J. MELICHERCIKOVA, M. PESL, K. MICHALOVA

Down-regulation of vinculin upon MK886-induced apoptosis in LN18 glioblastoma cells (517 — 526)

A. M. MAGRO, A. D. MAGRO, C. CUNNINGHAM, M. R. MILLER

B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration (527 — 535)

W. LUCZYNSKI, A. STASIAK-BARMUTA, J. PISZCZ, E. ILENDO, O. KOWALCZUK, M. KRAWCZUK-RYBAK

Fluorodeoxyglucose positron emission tomography in multiple myeloma, solitary plasmocytoma and monoclonal gammapathy of unknown significance (536 — 540)

Z. ADAM, K. BOLCAK, J. STANICEK, T. BUCHLER, L. POUR, M. KREJCI, J. PRASEK, J. NEUBAUER, J. VORLICEK, R. HAJEK

Expression of new prognostic markers, peripheral-type benzodiazepine receptor and carbonic anhydrase IX, in human breast and ovarian carcinoma cell lines (541 — 548)

L. HUNAKOVA, J. BODO, J. CHOVANCOVA, G. SULIKOVA, S. PASTOREKOVA, J. SEDLAK

Risk of secondary malignancies in testicular tumors (549 — 555)

H. SIFFNEROVA, D. KRALOVA